LAS VEGAS, NV--(Marketwired - Feb 10, 2015) - Alkame Holdings, Inc. (
Alkame's patented technology creates water with several unique properties which allow the body to absorb and utilize it more efficiently and help to achieve an optimal pH balance. This patented technology also increases the available oxygen content and absorbability which equates to more fuel for improved metabolic efficiency, boosted immune system, and improved cardio respiratory function.
Robert K. Eakle, Alkame CEO said, "Approval of the 'The Ultimate Health & Wellness Water' trademark represents a significant milestone for Alkame. We now can effectively utilize the marketing tagline 'The Ultimate Health & Wellness Water' on all marketing materials, labels and packaging. Our Company has already gained the attention of the industry by being recognized as the 'Healthy' Water Company. We look forward to our ongoing plans for distribution and continue educating consumers on the natural health benefits of alkaline water, and how it can play a pivotal role for those who are health-conscious consumers focused on nutrition, weight loss, energy, anti-aging and other health related issues."
About Alkame Holdings, Inc. (ALKM)
Alkame Holdings, Inc. is a publicly traded health and technology holding company with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiary, Alkame Water, Inc., markets and distributes micro-clustered, alkaline, antioxidant and oxygenated bottled water utilizing an exclusive patented formula and technology. Alkame uses this patented technology to create water with several unique properties which allow the body to absorb and utilize it more efficiently and help to achieve an optimal pH balance. This patented technology also increases the available oxygen content and absorbability which equates to more fuel for improved metabolic efficiency, boosted immune system, and improved cardio respiratory function.
For more information visit: www.alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.